These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36557069)

  • 1. Meta-Analysis of Survival Effects of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1).
    Jeong SY; Lee KJ; Cha J; Park SY; Kim HS; Kim JH; Lee JJ; Kim N; Park ST
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of receptor tyrosine kinase-like orphan receptor (ROR) family in cancer: A meta-analysis.
    Saleh RR; Antrás JF; Peinado P; Pérez-Segura P; Pandiella A; Amir E; Ocaña A
    Cancer Treat Rev; 2019 Jul; 77():11-19. PubMed ID: 31174180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the prognostic significance of receptor tyrosine kinase-like orphan receptor 1 (ROR1) in lung carcinoma and its relation to lymphangiogenesis and epithelial mesenchymal transition.
    Heabah NAE; Darwish SA; Eid AM
    Pathol Res Pract; 2023 Aug; 248():154703. PubMed ID: 37481855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.
    Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y
    Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target.
    Liu D; Gunther K; Enriquez LA; Daniels B; O'Mara TA; Tang K; Spurdle AB; Ford CE
    Sci Rep; 2020 Aug; 10(1):13906. PubMed ID: 32807831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer.
    Zhou JK; Zheng YZ; Liu XS; Gou Q; Ma R; Guo CL; Croce CM; Liu L; Peng Y
    Oncotarget; 2017 May; 8(20):32864-32872. PubMed ID: 28427197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
    Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
    Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Role of Receptor Tyrosine Kinase-Like Orphan Receptors in Intestinal-Type Gastric Cancer.
    Nema R; Patel P; Kumar A
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2125-2134. PubMed ID: 34319035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROR1 expression correlated with poor clinical outcome in human ovarian cancer.
    Zhang H; Qiu J; Ye C; Yang D; Gao L; Su Y; Tang X; Xu N; Zhang D; Xiong L; Mao Y; Li F; Zhu J
    Sci Rep; 2014 Jul; 4():5811. PubMed ID: 25056203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.
    Zhang S; Cui B; Lai H; Liu G; Ghia EM; Widhopf GF; Zhang Z; Wu CC; Chen L; Wu R; Schwab R; Carson DA; Kipps TJ
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17266-71. PubMed ID: 25411317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of ROR1 in Chemoresistance and EMT in Endometrial Cancer Cells.
    Lee KJ; Kim NH; Kim HS; Kim Y; Lee JJ; Kim JH; Cho HY; Jeong SY; Park ST
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241228
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of ROR1 has prognostic significance in triple negative breast cancer.
    Chien HP; Ueng SH; Chen SC; Chang YS; Lin YC; Lo YF; Chang HK; Chuang WY; Huang YT; Cheung YC; Shen SC; Hsueh C
    Virchows Arch; 2016 May; 468(5):589-95. PubMed ID: 26874851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy.
    Shabani M; Naseri J; Shokri F
    Expert Opin Ther Targets; 2015 Jul; 19(7):941-55. PubMed ID: 25835638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting ROR1 identifies new treatment strategies in hematological cancers.
    Karvonen H; Niininen W; Murumägi A; Ungureanu D
    Biochem Soc Trans; 2017 Apr; 45(2):457-464. PubMed ID: 28408486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
    Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
    J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor tyrosine kinase-like orphan receptor 1, a target of NKX2-1/TTF-1 lineage-survival oncogene, inhibits apoptosis signal-regulating kinase 1-mediated pro-apoptotic signaling in lung adenocarcinoma.
    Ida L; Yamaguchi T; Yanagisawa K; Kajino T; Shimada Y; Suzuki M; Takahashi T
    Cancer Sci; 2016 Feb; 107(2):155-61. PubMed ID: 26661061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.
    Cui B; Zhang S; Chen L; Yu J; Widhopf GF; Fecteau JF; Rassenti LZ; Kipps TJ
    Cancer Res; 2013 Jun; 73(12):3649-60. PubMed ID: 23771907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies.
    Daneshmanesh AH; Porwit A; Hojjat-Farsangi M; Jeddi-Tehrani M; Tamm KP; Grandér D; Lehmann S; Norin S; Shokri F; Rabbani H; Mellstedt H; Österborg A
    Leuk Lymphoma; 2013 Apr; 54(4):843-50. PubMed ID: 22988987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial.
    Parker BA; Shatsky RA; Schwab RB; Wallace AM; ; Wolf DM; Hirst GL; Brown-Swigart L; Esserman LJ; van 't Veer LJ; Ghia EM; Yau C; Kipps TJ
    Breast Cancer Res Treat; 2023 Jun; 199(2):281-291. PubMed ID: 37029329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROR1 associates unfavorable prognosis and promotes lymphoma growth in DLBCL by affecting PI3K/Akt/mTOR signaling pathway.
    Mao Y; Xu L; Wang J; Zhang L; Hou N; Xu J; Wang L; Yang S; Chen Y; Xiong L; Zhu J; Fan W; Xu J
    Biofactors; 2019 May; 45(3):416-426. PubMed ID: 30801854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.